Frontiers in Pharmacology | Renal Pharmacology

Original Research

Published on 21 Jan 2025

Shenshuaikang enema restores the intestinal barrier and microbiota-gut-kidney axis balance to alleviate chronic kidney disease via NF-κB pathway

in Renal Pharmacology

Yan Ye
Xiaopeng Huang
Xueying Li
Fei Gao
Wenzhen Zhong
Anqi Tang
Liangbin Zhao
Dengpiao Xie
Naijing Ye

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1453668

610 views

Editorial

Published on 21 Jan 2025

Editorial: Women in renal pharmacology 2023

in Renal Pharmacology

Nuria Lloberas
Laure Elens
Brenda de winter

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1519295

282 views

Review

Published on 14 Jan 2025

Current status and prospects of traditional Chinese medicine combined with stem cell therapy for chronic kidney disease

in Renal Pharmacology

Tianyang Qian
Yining He
Chao Han
Ruxue Yan
Weiming He

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1505206

624 views

Original Research

Published on 13 Jan 2025

Danshen injection ameliorates unilateral ureteral obstruction-induced renal fibrosis by inhibiting ferroptosis via activating SIRT1/GPX4 pathway

in Renal Pharmacology

Yiwen Cao
Huan Zhao
Shuyin Lin
Junqi Chen
Jingli Xiong
Zhijun Zeng
Ziyu Long
Yingru Su
Yingqi Zhong
Lingru Zhao

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1503628

620 views

Review

Published on 13 Jan 2025

Ferroptosis in kidney disease: a bibliometric analysis from 2012 to 2024

in Renal Pharmacology

Yuxin Hu
Jingyi Tang
Hanzhang Hong
Yexin Chen
Beibei Ye
Ziheng Gao
Gegongming Zhu
Lin Wang
Weijing Liu
Yaoxian Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1507574

823 views

Original Research

Published on 09 Jan 2025

Safety assessment of tolvaptan: real-world adverse event analysis using the FAERS database

in Renal Pharmacology

Peiyang Cao
Qian Wang
Yan Wang
Qing Qiao
Liyuan Yan

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1509310

853 views

Original Research

Published on 07 Jan 2025

Research hotspots and frontiers of endoplasmic reticulum in glomerular podocytes: a bibliometric and visual analysis from 2005 to 2023

in Renal Pharmacology

Wang Junli
Hao Zhihong
Wang Lina
Ou Qiaoqun
Qu Jing
Hu Jiaqi
Shengyou Yu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1488340

538 views

Review

Published on 07 Jan 2025

Angiopoietin-like protein 4 dysregulation in kidney diseases: a promising biomarker and therapeutic target

in Renal Pharmacology

Yan Li
Yuxin Zhang
Mengxia Cao
Tingting Yuan
Santao Ou

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1475198

523 views

Original Research

Published on 07 Jan 2025

High mobility group box 1 (HMGB1) mediates nicotine-induced podocyte injury

in Renal Pharmacology

Sayantap Datta
Mohammad Atiqur Rahman
Saisudha Koka
Krishna M. Boini

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1540639

1,140 views
1 citation

Correction

Published on 06 Jan 2025

Corrigendum: Efficacy of Oroxylin A in ameliorating renal fibrosis with emphasis on Sirt1 activation and TGF-β/Smad3 pathway modulation

in Renal Pharmacology

Guangzhuang Li
Sentao Xian
Xianchao Cheng
Yunhua Hou
Wenqing Jia
Yukui Ma

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1548193

493 views

Original Research

Published on 06 Jan 2025

Curcumin nanocrystals ameliorate ferroptosis of diabetic nephropathy through glutathione peroxidase 4

in Renal Pharmacology

Mengjiao Xue
Yiwei Tian
Hua Zhang
Shijie Dai
Yangsheng Wu
Juan Jin
Jian Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1508312

511 views

Original Research

Published on 06 Jan 2025

The efficacy and safety of half-dose glucocorticoids combined with rituximab versus high-dose glucocorticoids for initial treatment of minimal change disease: a single-center experience

in Renal Pharmacology

Xueting Li
Peng Yan
Lu Zhang
Wei Qiao
Zhengbiao Xue
Xiangdong Fang
Ben Ke
Shuying Zhu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1403562

402 views

Systematic Review

Published on 03 Jan 2025

Protective effects and possible mechanisms of mesenchymal stem cells and mesenchymal stem cell-derived extracellular vesicles against kidney fibrosis in animal models: a systematic review and meta-analysis

in Renal Pharmacology

Yuanchen Lv
Zibo Hua
Xiaomei Lu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1511525

931 views

Original Research

Published on 03 Jan 2025

FGF21 ameliorates diabetic nephropathy through CDK1-dependently regulating the cell cycle

in Renal Pharmacology

Yudie Zhang
Fan Wang
Chongyang Zhang
Fan Yao
Bin Zhang
Yongping Zhang
Xiaobo Sun

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1500458

601 views

Original Research

Published on 03 Jan 2025

Purple corn extract improves benign prostatic hyperplasia by inhibiting 5 alpha-reductase type 2 and inflammation in testosterone propionate-induced rats

in Renal Pharmacology

Sung-Ok Kim
Arin Choi
Hee-Hwan Lee
Jae-Yong Lee
Sang Jae Park
Byung-Hak Kim

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1485072

418 views

Original Research

Published on 18 Dec 2024

Immunosuppressant nonadherence profile in kidney transplant recipients and the impact of medication adherence on transplant outcomes

in Renal Pharmacology

Zou Zhi-yu
Dai Lin-rui
Yu Chen-zhen
Chen Ren-jie
Yu Fei-hong
Chen Song
Chang Sheng
Zhang Wei-jie

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1493166

445 views

Navigation group

Articles

Shenshuaikang enema restores the intestinal barrier and microbiota-gut-kidney axis balance to alleviate chronic kidney disease via NF-κB pathway

Editorial: Women in renal pharmacology 2023

Current status and prospects of traditional Chinese medicine combined with stem cell therapy for chronic kidney disease

Danshen injection ameliorates unilateral ureteral obstruction-induced renal fibrosis by inhibiting ferroptosis via activating SIRT1/GPX4 pathway

Ferroptosis in kidney disease: a bibliometric analysis from 2012 to 2024

Safety assessment of tolvaptan: real-world adverse event analysis using the FAERS database

Research hotspots and frontiers of endoplasmic reticulum in glomerular podocytes: a bibliometric and visual analysis from 2005 to 2023

Angiopoietin-like protein 4 dysregulation in kidney diseases: a promising biomarker and therapeutic target

High mobility group box 1 (HMGB1) mediates nicotine-induced podocyte injury

Corrigendum: Efficacy of Oroxylin A in ameliorating renal fibrosis with emphasis on Sirt1 activation and TGF-β/Smad3 pathway modulation

Curcumin nanocrystals ameliorate ferroptosis of diabetic nephropathy through glutathione peroxidase 4

The efficacy and safety of half-dose glucocorticoids combined with rituximab versus high-dose glucocorticoids for initial treatment of minimal change disease: a single-center experience

Protective effects and possible mechanisms of mesenchymal stem cells and mesenchymal stem cell-derived extracellular vesicles against kidney fibrosis in animal models: a systematic review and meta-analysis

FGF21 ameliorates diabetic nephropathy through CDK1-dependently regulating the cell cycle

Purple corn extract improves benign prostatic hyperplasia by inhibiting 5 alpha-reductase type 2 and inflammation in testosterone propionate-induced rats

Immunosuppressant nonadherence profile in kidney transplant recipients and the impact of medication adherence on transplant outcomes